Cytomyx Holdings plc · Cambridge United Kingdom (London: CYX)
| 24-25 Signet Court | Phone: +44-1223-316-855 |
| Cambridge | Fax: +44-1223-360-732 |
| CB5 8LA | |
| United Kingdom | 
Map This Company |
Cytomyx Holdings plc Rankings
Company Description
For some, this company's market presence is a 'Cyt' for sore eyes. Cytomyx develops protein-based tools for early-stage drug discovery and development. Cytomyx manufactures a product line designed to predict and eliminate drug candidates due to issues of toxicity or poor efficacy. Cytomyx has two operating subsidiaries in the UK: Cytomyx Ltd and Cytocell Technologies. The company also operates Clinomics Biosciences, located in Albany, New York. In 2005 the company acquired Aptus Pharmaceuticals, which complements Cytomyx's drug screening technologies.
Cytomyx Holdings plc Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - London: CYX |
|---|---|
| Fiscal Year-End | September |
Executives
2 executives listed for Cytomyx Holdings plc's Cambridge, United Kingdom location.
| Chairman and CEO | Wei-Wu He | |
|---|---|---|
| General Manager and Director, Operations | Glen Gershon |